Cargando…
Reinfection in patients with COVID-19: a systematic review
BACKGROUND: With the continuation of the COVID-19 pandemic, some COVID-19 patients have become reinfected with the virus. Viral gene sequencing has found that some of these patients were reinfected by the different and others by same strains. This has raised concerns about the effectiveness of immun...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051013/ https://www.ncbi.nlm.nih.gov/pubmed/35488305 http://dx.doi.org/10.1186/s41256-022-00245-3 |
_version_ | 1784696468520566784 |
---|---|
author | Ren, Xiangying Zhou, Jie Guo, Jing Hao, Chunmei Zheng, Mengxue Zhang, Rong Huang, Qiao Yao, Xiaomei Li, Ruiling Jin, Yinghui |
author_facet | Ren, Xiangying Zhou, Jie Guo, Jing Hao, Chunmei Zheng, Mengxue Zhang, Rong Huang, Qiao Yao, Xiaomei Li, Ruiling Jin, Yinghui |
author_sort | Ren, Xiangying |
collection | PubMed |
description | BACKGROUND: With the continuation of the COVID-19 pandemic, some COVID-19 patients have become reinfected with the virus. Viral gene sequencing has found that some of these patients were reinfected by the different and others by same strains. This has raised concerns about the effectiveness of immunity after infection and the reliability of vaccines. To this end, we conducted a systematic review to assess the characteristics of patients with reinfection and possible causes. METHODS: A systematic search was conducted across eight databases: PubMed, Embase, Web of Science, The Cochrane Library, CNKI, WanFang, VIP and SinoMed from December 1, 2019 to September 1, 2021. The quality of included studies were assessed using JBI critical appraisal tools and Newcastle–Ottawa Scale. RESULTS: This study included 50 studies from 20 countries. There were 118 cases of reinfection. Twenty-five patients were reported to have at least one complication. The shortest duration between the first infection and reinfection was 19 days and the longest was 293 days. During the first infection and reinfection, cough (51.6% and 43.9%) and fever (50% and 30.3%) were the most common symptoms respectively. Nine patients recovered, seven patients died, and five patients were hospitalized, but 97 patients’ prognosis were unknown. B.1 is the most common variant strain at the first infection. B.1.1.7, B.1.128 and B.1.351 were the most common variant strains at reinfection. Thirty-three patients were infected by different strains and 9 patients were reported as being infected with the same strain. CONCLUSIONS: Our research shows that it is possible for rehabilitated patients to be reinfected by SARS-COV-2. To date, the causes and risk factors of COVID-19 reinfection are not fully understood. For patients with reinfection, the diagnosis and management should be consistent with the treatment of the first infection. The public, including rehabilitated patients, should be fully vaccinated, wear masks in public places, and pay attention to maintaining social distance to avoid reinfection with the virus. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41256-022-00245-3. |
format | Online Article Text |
id | pubmed-9051013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-90510132022-04-29 Reinfection in patients with COVID-19: a systematic review Ren, Xiangying Zhou, Jie Guo, Jing Hao, Chunmei Zheng, Mengxue Zhang, Rong Huang, Qiao Yao, Xiaomei Li, Ruiling Jin, Yinghui Glob Health Res Policy Review BACKGROUND: With the continuation of the COVID-19 pandemic, some COVID-19 patients have become reinfected with the virus. Viral gene sequencing has found that some of these patients were reinfected by the different and others by same strains. This has raised concerns about the effectiveness of immunity after infection and the reliability of vaccines. To this end, we conducted a systematic review to assess the characteristics of patients with reinfection and possible causes. METHODS: A systematic search was conducted across eight databases: PubMed, Embase, Web of Science, The Cochrane Library, CNKI, WanFang, VIP and SinoMed from December 1, 2019 to September 1, 2021. The quality of included studies were assessed using JBI critical appraisal tools and Newcastle–Ottawa Scale. RESULTS: This study included 50 studies from 20 countries. There were 118 cases of reinfection. Twenty-five patients were reported to have at least one complication. The shortest duration between the first infection and reinfection was 19 days and the longest was 293 days. During the first infection and reinfection, cough (51.6% and 43.9%) and fever (50% and 30.3%) were the most common symptoms respectively. Nine patients recovered, seven patients died, and five patients were hospitalized, but 97 patients’ prognosis were unknown. B.1 is the most common variant strain at the first infection. B.1.1.7, B.1.128 and B.1.351 were the most common variant strains at reinfection. Thirty-three patients were infected by different strains and 9 patients were reported as being infected with the same strain. CONCLUSIONS: Our research shows that it is possible for rehabilitated patients to be reinfected by SARS-COV-2. To date, the causes and risk factors of COVID-19 reinfection are not fully understood. For patients with reinfection, the diagnosis and management should be consistent with the treatment of the first infection. The public, including rehabilitated patients, should be fully vaccinated, wear masks in public places, and pay attention to maintaining social distance to avoid reinfection with the virus. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41256-022-00245-3. BioMed Central 2022-04-29 /pmc/articles/PMC9051013/ /pubmed/35488305 http://dx.doi.org/10.1186/s41256-022-00245-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Ren, Xiangying Zhou, Jie Guo, Jing Hao, Chunmei Zheng, Mengxue Zhang, Rong Huang, Qiao Yao, Xiaomei Li, Ruiling Jin, Yinghui Reinfection in patients with COVID-19: a systematic review |
title | Reinfection in patients with COVID-19: a systematic review |
title_full | Reinfection in patients with COVID-19: a systematic review |
title_fullStr | Reinfection in patients with COVID-19: a systematic review |
title_full_unstemmed | Reinfection in patients with COVID-19: a systematic review |
title_short | Reinfection in patients with COVID-19: a systematic review |
title_sort | reinfection in patients with covid-19: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051013/ https://www.ncbi.nlm.nih.gov/pubmed/35488305 http://dx.doi.org/10.1186/s41256-022-00245-3 |
work_keys_str_mv | AT renxiangying reinfectioninpatientswithcovid19asystematicreview AT zhoujie reinfectioninpatientswithcovid19asystematicreview AT guojing reinfectioninpatientswithcovid19asystematicreview AT haochunmei reinfectioninpatientswithcovid19asystematicreview AT zhengmengxue reinfectioninpatientswithcovid19asystematicreview AT zhangrong reinfectioninpatientswithcovid19asystematicreview AT huangqiao reinfectioninpatientswithcovid19asystematicreview AT yaoxiaomei reinfectioninpatientswithcovid19asystematicreview AT liruiling reinfectioninpatientswithcovid19asystematicreview AT jinyinghui reinfectioninpatientswithcovid19asystematicreview |